Abstract
Introduction/BackgroundAchieving a status of no residual disease (CC 0) following cytoreductive surgery in advanced epithelial ovarian cancer (EOC) is crucial for favourable prognoses in affected women. The challenge lies in...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have